GeneDx Holdings (WGS) Tax Provisions (2022 - 2026)

GeneDx Holdings (WGS) has reported Tax Provisions for 5 consecutive years, with -$518000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Tax Provisions fell 110.57% year-over-year to -$518000.0 in Q2 2026; TTM through Jun 2026 was $65000.0, a 50.0% decrease from a year earlier, with the FY2025 full-year figure at -$116000.0, up 66.18% from the prior year.
• Tax Provisions was -$518000.0 for Q2 2026 at GeneDx Holdings, down from $900000.0 in the prior quarter.
• Over five years, Tax Provisions peaked at $900000.0 in Q1 2026 and troughed at -$49.1 million in Q2 2022.
• A 5-year average of -$2.9 million and a median of -$147000.0 in 2023 frame the typical range for Tax Provisions.
• The widest YoY moves for Tax Provisions: up 625.53% in 2025, down 2250.0% in 2025.
• Over 5 years, Tax Provisions stood at $42000.0 in 2022, then slumped by 1078.57% to -$411000.0 in 2023, then surged by 94.16% to -$24000.0 in 2024, then plunged by 2250.0% to -$564000.0 in 2025, then advanced by 8.16% to -$518000.0 in 2026.
• The last three Tax Provisions figures came in at -$518000.0 (Q2 2026), $900000.0 (Q1 2026), and -$564000.0 (Q4 2025), per Business Quant data.